DSCAM and Alzheimer disease: Studies are warranted to investigate whether DSCAM is overexpressed in the hippocampus of DS and AD patients, how APP and DSCAM interact at both the expression and functional levels, and if and how DSCAM alone alters hippocampal synaptoplastic processes underlying learning and memory.